PharmaShots | Incisive News in 3 Shots

Subscribe Now

Acute Lymphoblastic Leukemia

Jazz's Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Receives the US FDA's Approval for Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Jazz's Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Receives the US FDA's Approval for Acute Lymphoblastic Leukem...

July 1, 2021

Precision BioSciences Receives the US FDA's Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphoblastic Leukemia

Precision BioSciences Receives the US FDA's Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphobl...

August 20, 2020

Bristol-Myers' Sprycel (dasatinib) Receives CHMP Recommendation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)

Bristol-Myers' Sprycel (dasatinib) Receives CHMP Recommendation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia...

December 18, 2018

BMS's Sprycel (dasatinib) sBLA Receives Positive Response from the US FDA

BMS's Sprycel (dasatinib) sBLA Receives Positive Response from the US FDA

August 30, 2018

Amgen's BLINCYTO (blinatumomab- BiTE) Receives EU Expanded approval for pediatric 2L+ B-cell-ALL

Amgen's BLINCYTO (blinatumomab- BiTE) Receives EU Expanded approval for pediatric 2L+ B-cell-ALL

August 30, 2018

Servier's Asparlas (calaspargase pegol-mknl) Receives FDA's Approval for Acute Lymphoblastic Leukemia (ALL)

Servier's Asparlas (calaspargase pegol-mknl) Receives FDA's Approval for Acute Lymphoblastic Leukemia (ALL)

March 1, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us